Regulation 19 Determination whether a substance is a drug and recovery of cost
The provisions of this regulation shall apply to the determination of any question arising as to whether a substance supplied by a doctor, or by a pharmacist on the prescription of a doctor, was a drug for the purposes of pharmaceutical services.
If a Health Board are of the opinion that any substance supplied by a doctor or a pharmacist on the prescription of a doctor was not a drug for the purposes of pharmaceutical services, they shall—
notify the doctor in writing of their opinion; and
inform him that he may, within 1 week from the date of receipt of such notice, require the Health Board to refer the question for determination under this regulation.
Any question to which this regulation applies—
shall, if the doctor concerned so requires pursuant to paragraph (2); or
may, in any other case in which a Health Board think fit,
be referred by the Health Board concerned to the area medical committee for determination.
Where a question is referred to an area medical committee pursuant to paragraph (3), the Health Board concerned shall inform the area pharmaceutical committee of the referral.
As soon as may be practicable after a question is referred to an area medical committee, that committee shall—
send to the doctor to whom the question relates a written statement indicating the nature of the question referred;
inform the doctor that he may—
submit to the committee a statement-in-answer; or
appear in person before the committee for the purposes of making representations.
An area medical committee shall, where the doctor wishes to appear before and is heard by the committee, allow representatives of the Health Board concerned to appear before the committee for the purpose of making representations.
After due consideration of any statement-in-answer or representations, whether made in writing or orally, made pursuant to paragraph (5) or (6), an area medical committee shall determine the question referred and shall inform the doctor and the Health Board concerned and also the Secretary of State of their determination by sending them a copy of it.
Where in relation to a determination made by an area medical committee under paragraph (7)—
the doctor concerned notifies the Secretary of State within 4 weeks from the date on which he receives notification of the determination that he is dissatisfied with the determination;
the Health Board concerned notify the Secretary of State within 4 weeks from the date on which they receive notification of the determination that they are dissatisfied with the determination; or
whether or not the doctor or the Health Board concerned notify him under subparagraph (a) or (b), the Secretary of State is dissatisfied with the determination,
the Secretary of State shall refer the question for determination by a referee or referees not exceeding 3 in number.
For the purposes of paragraph (8), the referee or referees appointed shall not be an officer or officers of the Secretary of State and—
where 1 referee only is appointed, he shall be a doctor; and
where more than 1 referee is appointed, at least 1 shall be a doctor.
Where in relation to a question to which this regulation applies there is a determination—
by an area medical committee pursuant to paragraph (7); or
by a referee or referees pursuant to paragraph (8),
that a substance concerned was not a drug for the purposes of pharmaceutical services, the Health Board concerned shall, in respect of that substance, recover from the doctor concerned a sum calculated in accordance with paragraph (11).
For the purposes of paragraph (10), the sum to be recovered by a Health Board shall be—
where the substance concerned was an ingredient in a preparation of which other ingredients were drugs for the purposes of pharmaceutical services, the cost of that substance calculated in accordance with sub-paragraph (b) together with half the amount of the dispensing fee payable in respect of the supply of the preparation; or
in other cases, a sum calculated in accordance with the method set forth in the drug tariff for calculating the payment for drugs and preparations not specified therein.